Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DRAFFT 2 logo

The DRAFFT2 –Distal Radius Acute Fracture Fixation Trial 2 has now opened its first 2 sites for recruitment. Peterborough City Hospital and Royal Stoke University Hospital are now recruiting patients for the trial which is comparing two different ways of fixing bones within the broken wrist: K-wires and plaster cast.

Most fractures can be treated without the need for surgery. However, for the more serious wrist injuries, the treating surgeon may recommend an operation to restore the normal position of the wrist bones. This study is for patients who are having surgery for their broken wrist.

Both techniques are used routinely throughout the NHS, but we don’t know which one works best.

  • This is a multi-centre, multi-surgeon, parallel, two-arm, randomised controlled trial. It is planned to run across 16 sites in the UK and recruit 476 patients.
  • Patients over the age of 16 with a dorsally displaced fracture of the distal radius are potentially eligible for the trial.
  • We will ask all patients to report their own recovery using a questionnaire at 3 months, 6 months and 12 months after the treatment. The trial will also collect important information for secondary outcomes on quality of life, complications, resource use, costs and comparative cost effectiveness.

For more information and contacts, please visit https://www.ndorms.ox.ac.uk/clinical-trials/current-trials-and-studies/drafft-2

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.